Concepedia

Jonathan D. Bargh

JD

6

Publications

223

Citations

6

H-Index

2020

Active since

Affiliations

University of Cambridge(Current)

Cancer Research UK

AstraZeneca (United Kingdom)

Cancer Research UK Cambridge Center

Age UK

Jonathan D. Bargh is an author at University of Cambridge specializing in drug discovery, medicine, and protein engineering.

ORCID

Top concepts

Publications per year

2020–2023

6

Publications

6

Sulfatase-cleavable linkers for antibody-drug conjugates

Jonathan D. Bargh, Stephen J. Walsh, Albert Isidro‐Llobet et al. · Chemical Science · 2020 · 72 citations · Full text

Rapid and robust cysteine bioconjugation with vinylheteroarenes

Hikaru Seki, Stephen J. Walsh, Jonathan D. Bargh et al. · Chemical Science · 2021 · 41 citations · Full text

, , +16

A dual-enzyme cleavable linker for antibody–drug conjugates

Jonathan D. Bargh, Stephen J. Walsh, Nicola Ashman et al. · Chemical Communications · 2021 · 35 citations · Full text

General dual functionalisation of biomacromolecules <i>via</i> a cysteine bridging strategy

Stephen J. Walsh, Jessica Iegre, Hikaru Seki et al. · Organic & Biomolecular Chemistry · 2020 · 28 citations · Full text

All-in-one disulfide bridging enables the generation of antibody conjugates with modular cargo loading

Friederike M. Dannheim, Stephen J. Walsh, Carolina T. Orozco et al. · Chemical Science · 2022 · 25 citations · Full text

, , +17

Rows per page

1–5 of 6